From Code to Cash: A Guide to U.S. Medical Device Reimbursement Rates

Securing a U.S. medical device code is only half the battle; the next challenge is determining its payment rate. This episode breaks down the three primary pathways for setting reimbursement rates in the United States. We explore the roles of CMS and private payers, detailing the specifics of the cross-walking and gap-filling processes, including key timelines like the annual summer public meetings. We also uncover the most common pitfalls that can delay or diminish your device's earning potential, from unfavorable comparisons to the complexities of negotiating with hundreds of individual payers. Key Questions: * Once a device has a code, how is its reimbursement rate actually set? * What is CMS's "cross-walk" process, and what are its biggest risks? * How does "gap-filling" work for novel technologies without a comparator? * What is the typical timeline for the gap-fill process and when do key decisions happen? * How do private payers determine payment rates, and how does it differ from Medicare? * What are the most common pitfalls that can undervalue a new medical device? * Why is the first year of a new code often financially unpredictable? * How can you build a strategy to navigate both CMS and private payer negotiations? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.